Using bisphosphonates to control the pain of bone metastases: evidence-based guidelines for palliative care. - Wikidata - awgldk - TriplyDB

Using bisphosphonates to control the pain of bone metastases: evidence-based guidelines for palliative care.

Using bisphosphonates to control the pain of bone metastases: evidence-based guidelines for palliative care.

http://www.wikidata.org/entity/Q34162842

about

Bisphosphonates for the relief of pain secondary to bone metastases.Metastatic bone disease and tumour-induced hypercalcaemia: the role of bisphosphonates.The use of bisphosphonates in patients with breast cancer.Clinical guidelines.Orofacial pain in cancer: part I--mechanisms.Improved efficacy of intramuscular weekly administration of clodronate 200 mg (100 mg twice weekly) compared with 100 mg (once weekly) for increasing bone mineral density in postmenopausal osteoporosis.Does pamidronate enhance the analgesic effect of radiotherapy? A randomized trial.Evidence-based clinical guidelines for palliative care: the work of the APM Science Committee

P2860

Q32139406-404F41AF-579F-4F37-80F3-72D0B60DDDAF Q34686881-C6419957-B349-457B-933A-4836B0EE279C Q35039488-CB5120E5-6878-43BA-A1CE-927FC8976831 Q35161016-D909991D-EB4B-4967-A328-0C369C418227 Q36831523-1F40766C-843D-43B1-9360-1AD6AA831BD2 Q44650580-3F940CA8-3B8B-414A-9E11-C175F5139775 Q46855521-3FC8911A-816F-45B8-917B-5954AE3EF881 Q56452446-A36FB638-29F9-4057-A4FB-70FABB98B7B8

P2860

Using bisphosphonates to control the pain of bone metastases: evidence-based guidelines for palliative care.

http://www.wikidata.org/entity/Q34162842

description

2000 nî lūn-bûn

@nan

2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Using bisphosphonates to contr ...... uidelines for palliative care.

@ast

Using bisphosphonates to contr ...... uidelines for palliative care.

@en

Using bisphosphonates to contr ...... uidelines for palliative care.

@nl

type

label

Using bisphosphonates to contr ...... uidelines for palliative care.

@ast

Using bisphosphonates to contr ...... uidelines for palliative care.

@en

Using bisphosphonates to contr ...... uidelines for palliative care.

@nl

prefLabel

Using bisphosphonates to contr ...... uidelines for palliative care.

@ast

Using bisphosphonates to contr ...... uidelines for palliative care.

@en

Using bisphosphonates to contr ...... uidelines for palliative care.

@nl

P1433

Q34162842-747FEBE6-F3C6-48B1-9BAE-D51D5B93CEB4

P1476

Q34162842-DE52DB2D-552F-411E-B4DA-0425BEB9F44E

P2093

Q34162842-80ED37EE-3FB8-485B-A007-DB5E48CC9B92

Q34162842-AAB851A5-CDAE-4027-A606-69ACE2B526A0

Q34162842-CCC069F5-5636-465A-8667-5DBC9DB3D615

Q34162842-DA3CBBDA-3C4E-4E0E-BE6D-8ACDD50E7FFC

P2860

Q34162842-06D8BDEC-AEAB-4550-A08E-FEB94BCE01C4

Q34162842-09D685F5-B586-499A-90F5-07B348B0B0F5

Q34162842-2B44567F-6DB5-47CC-97F5-4CDAEA286D41

Q34162842-2F1BC094-3D20-4F6B-A3C7-3A50D46BDE25

Q34162842-32CCC7E1-32A1-48A7-A244-48C51438F73C

Q34162842-43C5AA73-6612-4976-8BA0-0999753757DA

Q34162842-5FC2E5D8-EED5-4A2E-A950-A61F10C2B318

Q34162842-7E255D16-D6BB-4F9C-B404-875EB2C52F59

Q34162842-CA5E049A-85CB-48BC-8547-F5AA5FD793F4

Q34162842-CC89B1C9-2895-477A-A552-22DDF1E5C6F5

P304

Q34162842-878DA45B-DCC8-40BB-99E5-6BD5B1712203

P31

Q34162842-47523DF0-D032-4A56-8DF9-29F9210E3248

P356

Q34162842-B06AEDDA-EAAB-44CC-AF95-AE61CF6DCE2E

P433

Q34162842-5F04792C-F944-4E78-B892-9B43665E0E99

P478

Q34162842-B5B05DD4-EBF6-47AC-A268-FD4A731E9D19

P50

Q34162842-822C5E64-1D2E-4845-AF04-840CA6859864

Q34162842-E251D223-54AD-4AB0-9909-10E95B598117

P577

Q34162842-6D309E1A-2982-4097-A761-2008BC6807CF

P5875

Q34162842-DAD9FFEC-9362-4727-A7E5-80525ADD1785

P698

Q34162842-22566CBC-7538-4508-A733-BC6B17D2192C

P356

026921600701536372

P1433

Palliative Medicine

P1476

Using bisphosphonates to contr ...... uidelines for palliative care.

@en

P2093

H Anderson

http://www.w3.org/2001/XMLSchema#string

K Mannix

http://www.w3.org/2001/XMLSchema#string

M Bennett

http://www.w3.org/2001/XMLSchema#string

M Lloyd-Williams

http://www.w3.org/2001/XMLSchema#string

P2860

Metastases in carcinoma; analysis of 1000 autopsied cases.

High-dose intravenous pamidronate for metastatic bone pain.

Metabolic effects of pamidronate in patients with metastatic bone disease.

Concomitant i.v. and oral clodronate in the relief of bone pain--a double-blind placebo-controlled study in patients with prostate cancer

Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. The Aredia Multinational Cooperative Group.

Pamidronate in patients with painful bone metastases, who failed initial treatment with hormones and/or chemotherapy.

Effect of oral clodronate on bone pain. A controlled study in patients with metastic prostatic cancer.

Should bisphosphonates be part of the standard therapy of patients with multiple myeloma or bone metastases from other cancers? An evidence-based review.

Palliation of painful bone metastases from prostate cancer using sodium etidronate: results of a randomized, prospective, double-blind, placebo-controlled study.

The effect of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast cancer.

P304

455-461

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1191/026921600701536372

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2000-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12111254

http://www.w3.org/2001/XMLSchema#string

P698

11219875

http://www.w3.org/2001/XMLSchema#string